| BGF EURO-MARKETS I4 EUR | RV EURO | 17,47% | 44,91% | 47,30% | 132,93% |
| CAIXABANK SMALL & MID CAPS ESPAÑA, FI ESTANDAR | RV ESPAÑA SMALL/MID CAP | 16,83% | 62,98% | 67,82% | 132,93% |
| GOLDMAN SACHS ASIA EQUITY PORTFOLIO R GBP DIS | RVI ASIA EX-JAPÓN | 46,93% | 62,95% | 16,94% | 132,92% |
| ALLIANZ GLOBAL SMALL CAP EQUITY AT USD | RVI GLOBAL SMALL/MID CAP | 33,13% | 46,85% | 33,28% | 132,84% |
| UBS (LUX) EQUITY FUND - EURO COUNTRIES OPPORTUNITY (EUR) Q-ACC | RV EURO | 23,51% | 43,52% | 40,79% | 132,84% |
| GOLDMAN SACHS ASIA EQUITY PORTFOLIO I GBP DIS | RVI ASIA EX-JAPÓN | 46,79% | 62,68% | 16,79% | 132,83% |
| PICTET - BIOTECH HI EUR | RVI BIOTECNOLOGÍA | 80,93% | 88,10% | 43,38% | 132,83% |
| PICTET - JAPANESE EQUITY OPPORTUNITIES P DY JPY | RVI JAPÓN | 28,32% | 45,79% | 45,69% | 132,82% |
| MSIF SUSTAINABLE EMERGING MARKETS EQUITY A (USD) | RVI EMERGENTES | 58,02% | 88,99% | 54,63% | 132,79% |
| POLAR CAPITAL HEALTHCARE BLUE CHIP I GBP CAP | RVI SALUD | 29,45% | 24,91% | 45,65% | 132,79% |
